Approval and delay status of United States -approved new drugs (2010-2023) in European Union, Japan, and China.
- DOI
- 10.1186/s12913-026-15081-1
- Published
- 2026 Jul 13
- Container
- BMC health services research
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12913-026-15081-1,
title = {Approval and delay status of United States -approved new drugs (2010-2023) in European Union, Japan, and China.},
author = {Mo Q and He J and Guo Q and Wei H and Liu Y and Yang Y},
year = {2026},
journal = {BMC health services research},
doi = {10.1186/s12913-026-15081-1},
url = {https://doi.org/10.1186/s12913-026-15081-1}
}RIS
TY - JOUR TI - Approval and delay status of United States -approved new drugs (2010-2023) in European Union, Japan, and China. AU - Mo Q AU - He J AU - Guo Q AU - Wei H AU - Liu Y AU - Yang Y PY - 2026 JO - BMC health services research DO - 10.1186/s12913-026-15081-1 UR - https://doi.org/10.1186/s12913-026-15081-1 ER -
APA
Q, M., J, H., Q, G., H, W., Y, L., & Y, Y. (2026). Approval and delay status of United States -approved new drugs (2010-2023) in European Union, Japan, and China.. BMC health services research. https://doi.org/10.1186/s12913-026-15081-1
Source records
- pubmed · retrieved 2026-09-25T18:56:54.052Z
- europe-pmc · retrieved 2026-09-25T18:56:54.039Z